Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Aim: To assess the performance of the QRISK score for predicting cardiovascular disease (CVD) in an independent UK sample from general practice and compare with the Framingham score. Design: Prospective open cohort study Setting: UK general practices contributing to the THIN and QRESEARCH databases. Cohort: The THIN validation cohort consisted of 1.07 million patients, aged 35–74 years registered at 288 THIN practices between 1 January 1995 and 1 April 2006. The QRESEARCH validation cohort consisted of 0.61 million patients from 160 practices (one-third of the full database) with data until 1 January 2007. Patients receiving statins, those with diabetes or CVD at baseline were excluded. End point: First diagnosis of CVD (myocardial infarction, coronary heart disease (CHD), stroke and transient ischaemic attack) recorded on the clinical computer system during the study period. Exposures: Age, sex, smoking status, systolic blood pressure, total/high-density lipoprotein cholesterol ratio, body mass index, family history of premature CHD, deprivation and antihypertensive medication. Results: Characteristics of both cohorts were similar, except that THIN patients were from slightly more affluent areas and had lower recording of family history of CHD. QRISK performed better than Framingham for every discrimination and calibration statistic in both cohorts. Framingham overpredicted risk by 23% in the THIN cohort, while QRISK underpredicted risk by 12%. Conclusion: This analysis demonstrated that QRISK is better calibrated to the UK population than Framingham and has better discrimination. The results suggest that QRISK is likely to provide more appropriate risk estimates than Framingham to help identify patients at high risk of CVD in the UK.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Backer, G. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00347-6 · Cited by 2,251
Woodward, M., Brindle, P., & Tunstall-Pedoe, H. (2007) · Heart · doi:10.1136/hrt.2006.108167 · Cited by 667
Self-citationA systematic review and economic evaluation of statins for the prevention of coronary events
Ward, S., Lloyd Jones, M., Pandor, A., Holmes, M., Ara, R., Ryan, A., Yeo, W., & Payne, N. (2007) · Health Technology Assessment · doi:10.3310/hta11140 · Cited by 556 · cited 1×
“The statin HTA in the UK has identified a CVD event threshold of 20% in 10 years as the threshold for treatment of which most are non-fatal events.(15)”
BackgroundA new measure of prognostic separation in survival data
Royston, P., & Sauerbrei, W. (2004) · Statistics in Medicine · doi:10.1002/sim.1621 · Cited by 450 · cited 1×
“We calculated the area under the receiver operator curve statistic to assess discrimination (ie, ability of a risk prediction equation to distinguish between those who do and do not have a cardiovascular event during the follow-up period). We also calculated the D statistic”
Method
Cited by
Hippisley-Cox, J., Coupland, C., & Brindle, P. (2017) · BMJ · doi:10.1136/bmj.j2099 · Cited by 1,703
Self-citationPredicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2
Hippisley-Cox, J., Coupland, C., Vinogradova, Y., Robson, J., Minhas, R., Sheikh, A., & Brindle, P. (2008) · BMJ · doi:10.1136/bmj.39609.449676.25 · Cited by 1,459
Self-citationLoci influencing lipid levels and coronary heart disease risk in 16 European population cohorts
the ENGAGE Consortium (2009) · Nature Genetics · doi:10.1038/ng.269 · Cited by 854
Hippisley-Cox, J., & Coupland, C. (2009) · BMJ · doi:10.1136/bmj.b4229 · Cited by 479
Self-citationSiontis, G. C. M., Tzoulaki, I., Castaldi, P. J., & Ioannidis, J. P. A. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.09.007 · Cited by 459
Value and Limitations of Existing Scores for the Assessment of Cardiovascular Risk
Cooney, M. T., Dudina, A. L., & Graham, I. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.020 · Cited by 436
Hippisley-Cox, J., Coupland, C., Robson, J., Sheikh, A., & Brindle, P. (2009) · BMJ · doi:10.1136/bmj.b880 · Cited by 372
Self-citationHippisley-Cox, J., Coupland, C., Robson, J., & Brindle, P. (2010) · BMJ · doi:10.1136/bmj.c6624 · Cited by 364
Self-citationHippisley-Cox, J., & Coupland, C. (2012) · BMJ · doi:10.1136/bmj.e3427 · Cited by 351
Self-citationCardiovascular Disease Risk Assessment: Insights from Framingham
D’Agostino Sr., R. B., Pencina, M. J., Massaro, J. M., & Coady, S. (2013) · Global Heart · doi:10.1016/j.gheart.2013.01.001 · Cited by 329
Maguire, A., Blak, B. T., & Thompson, M. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1688 · Cited by 301
Screening for cardiovascular risk in asymptomatic patients
Berger, J. S., Jordan, C. O., Lloyd-Jones, D., & Blumenthal, R. S. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.066 · Cited by 238
Cooney, M. T., Dudina, A., D'Agostino, R., & Graham, I. M. (2010) · Circulation · doi:10.1161/circulationaha.109.852756 · Cited by 222
Lekadir, K., Galimzianova, A., Betriu, A., del Mar Vila, M., Igual, L., Rubin, D. L., Fernandez, E., Radeva, P., & Napel, S. (2017) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2016.2631401 · Cited by 212
Suicide-Related Events in Patients Treated with Antiepileptic Drugs
Arana, A., Wentworth, C. E., Ayuso-Mateos, J. L., & Arellano, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909801 · Cited by 205
Neighbourhood socioeconomic status and coronary heart disease in individuals between 40 and 50 years
Carlsson, A. C., Li, X., Holzmann, M. J., Wändell, P., Gasevic, D., Sundquist, J., & Sundquist, K. (2016) · Heart · doi:10.1136/heartjnl-2015-308784 · Cited by 51
Iyen-Omofoman, B., Hubbard, R. B., Smith, C. J., Sparks, E., Bradley, E., Bourke, A., & Tata, L. J. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-857 · Cited by 44
Robinson, L., Dickinson, C., Magklara, E., Newton, L., Prato, L., & Bamford, C. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-018677 · Cited by 26
Improving Cardiovascular Disease Prediction With Machine Learning Using Mental Health Data
Dorraki, M., Liao, Z., Abbott, D., Psaltis, P. J., Baker, E., Bidargaddi, N., Wardill, H. R., van den Hengel, A., Narula, J., & Verjans, J. W. (2024) · JACC: Advances · doi:10.1016/j.jacadv.2024.101180 · Cited by 19
Qiao, Q., Gao, W., Laatikainen, T., & Vartiainen, E. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2011.00692.x · Cited by 9
Metadata
- Authors
- Hippisley-Cox, J., Coupland, C., Vinogradova, Y., Robson, J., & Brindle, P.
- Venue
- Heart
- Publisher
- BMJ
- Published
- 2007-10-04
- Volume
- 94
- Issue
- 1
- Pages
- 34-39
- ISSN
- 1355-6037 (ISSN-L)
- 1468-201X
- OpenAlex
- W2151471101
- Cited by
- 227
- References
- 4
- FWCI
- 16.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.